Ajay Prakash Pasupulla

Prof. Dr. Ajay Prakash Pasupulla

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2002
Verified
Journal Article
Closed access
BSB Sivapathasundharam
B Sivapathasundharam
Ajay Prakash PasupullaAjay Prakash Pasupulla
Ajay Prakash Pasupulla
GSG Sivakumar
G Sivakumar

1 January 2022 in Materials Today: Proceedings
Verified
Journal Article
Closed access
Ajay Prakash PasupullaAjay Prakash Pasupulla
Ajay Prakash Pasupulla
HAHabtamu Abebe Agisho
Habtamu Abebe Agisho
Suresh SeetharamanSuresh Seetharaman
Suresh Seetharaman
SVS. Vijayakumar
S. Vijayakumar

31 July 2021 in Materials Today: Proceedings
Verified
Journal Article
Closed access
HPHari Prasadarao Pydi
Hari Prasadarao Pydi
Ajay Prakash PasupullaAjay Prakash Pasupulla
Ajay Prakash Pasupulla
VSvijayakumar Sivasundar
vijayakumar Sivasundar
HAHabtamu Abebe Agisho
Habtamu Abebe Agisho

22 February 2024 in Clinica Chimica Acta
Verified
Journal Article
Closed access
AKAvanthika Satish Kumar
Avanthika Satish Kumar
SVSneha Venkatesalu
Sneha Venkatesalu
SDShanmugapriya Dilliyappan
Shanmugapriya Dilliyappan
Ajay Prakash PasupullaAjay Prakash Pasupulla
Ajay Prakash Pasupulla
LPLavanya Prathap
Lavanya Prathap
ASAbimanyu Sugumaran
Abimanyu Sugumaran

1 January 2022 in Materials Today: Proceedings
Verified
Journal Article
Closed access
DSDilip Kumar Sharma
Dilip Kumar Sharma
GRGopala Krishna Rapaka
Gopala Krishna Rapaka
Ajay Prakash PasupullaAjay Prakash Pasupulla
Ajay Prakash Pasupulla
SJSushma Jaiswal
Sushma Jaiswal
KAKishori Abadar
Kishori Abadar
HKHarpreet Kaur
Harpreet Kaur

24 June 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MDMitiku Desalegn
Mitiku Desalegn
GGGelana Garoma
Gelana Garoma
HTHabtamu Tamrat
Habtamu Tamrat
ADAdane Desta
Adane Desta
Ajay Prakash PasupullaAjay Prakash Pasupulla
Ajay Prakash Pasupulla
Introduction: The best way to eradicate corona virus disease (COVID-19) viral infection is mass vaccination. Many studies demonstrate vaccination is associated with some local and systemic side effects. This study aimed to provide evidence on AstraZeneca COVID-19 vaccine side effects. Methodology: Institutional based cross-sectional survey was conducted among 254 health workers at Nigist Eleni Mohammed memorial comprehensive specialized hospital (from July 01/ 2021 to July 30/2021). Data were collected consecutively through self-administered online survey created on Google Forms of platform which had been randomly delivered via (Facebook or telegram pages). Demographic data of participants, side effect after first and second dose of vaccine were covered. Result: The prevalence of at least one side effect after first dose was 91.3% and after second dose was 67%. Injection site pain (63.8% vs. 50.4%), headache (48.8% vs. 33.5%), fever (38.8% vs. 20.9%), muscle pain (38.8% vs. 21.7%), fatigue (26% vs. 28.7%, tenderness at the site (27.6% vs. 21.7%), and joint pain (27.6% vs. 20.9%) were the most commonly reported side effects after first and second dose vaccine respectively. Most of participants reported that their symptoms emerged after 6hr of vaccination and only less than 5% of participant’s symptoms lasted more than 72hr of post vaccination. The younger age (≤29 year) were more susceptible to at least one side effect (χ 2 = 4.2; p = 0.04) after first dose. Conclusion: The prevalence of side effect after first and second dose vaccine was higher. Most of the symptoms were short lived and mild. This result might help to solve an emerging public health challenge (vaccine hesitancy) nurtured by misinformation related to vaccines safety.